Log in
Enquire now

List of Molecular Partners patents

List of Molecular Partners patents
List of Moog patents
List of Echogen Power Systems patents
List of Staton Techiya, LLC patents
List of companies in Porsche's investment portfolio
List of SBIR/STTR awards granted to HARP ENGINEERING LLC
Patents where
Current Assignee
Name
is
Molecular PartnersMolecular Partners
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9458211 Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

Patent 9458211 was granted and assigned to Molecular Partners on October, 2016 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9458211
October 4, 2016
‌
US Patent 11332501 Recombinant binding proteins and their use

Patent 11332501 was granted and assigned to Molecular Partners on May, 2022 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
11332501
May 17, 2022
‌
US Patent 8710187 Modified binding proteins inhibiting the VEGF-A receptor interaction

Patent 8710187 was granted and assigned to Molecular Partners on April, 2014 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
8710187
April 29, 2014
‌
US Patent 9284361 Designed repeat proteins binding to serum albumin

Patent 9284361 was granted and assigned to Molecular Partners on March, 2016 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9284361
March 15, 2016
‌
US Patent 11466062 Ankyrin repeat binding proteins and their uses

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
11466062
October 11, 2022
‌
US Patent 11578427 Designed ankyrin repeat domains with altered surface residues

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
11578427
February 14, 2023
‌
US Patent 9221892 Capping modules for designed ankyrin repeat proteins

Patent 9221892 was granted and assigned to Molecular Partners on December, 2015 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9221892
December 29, 2015
‌
US Patent 9163070 Designed ankyrin repeat proteins binding to platelet-derived growth factor

Patent 9163070 was granted and assigned to Molecular Partners on October, 2015 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9163070
October 20, 2015
‌
US Patent 9289466 Modified binding proteins inhibiting the VEGF-A receptor interaction

Patent 9289466 was granted and assigned to Molecular Partners on March, 2016 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9289466
March 22, 2016
‌
US Patent 9849158 Modified binding proteins inhibiting the VEGF-A receptor interaction

Patent 9849158 was granted and assigned to Molecular Partners on December, 2017 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9849158
December 26, 2017
‌
US Patent 10646542 Modified binding proteins inhibiting the VEGF-A receptor interaction

Patent 10646542 was granted and assigned to Molecular Partners on May, 2020 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
10646542
May 12, 2020
‌
US Patent 9775912 Designed repeat proteins binding to serum albumin

Patent 9775912 was granted and assigned to Molecular Partners on October, 2017 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9775912
October 3, 2017
‌
US Patent 10322190 Capping modules for designed ankyrin repeat proteins

Patent 10322190 was granted and assigned to Molecular Partners on June, 2019 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
10322190
June 18, 2019
‌
US Patent 9717802 Capping modules for designed ankyrin repeat proteins

Patent 9717802 was granted and assigned to Molecular Partners on August, 2017 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
9717802
August 1, 2017
‌
US Patent 10155791 Recombinant binding proteins and their use

Patent 10155791 was granted and assigned to Molecular Partners on December, 2018 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
10155791
December 18, 2018
‌
US Patent 11834504 DARPin based multi-specific t-cell engagers

Patent 11834504 was granted and assigned to Molecular Partners on December, 2023 by the United States Patent and Trademark Office.

Molecular Partners
Molecular Partners
Molecular Partners
Molecular Partners
United States Patent and Trademark Office
United States Patent and Trademark Office
11834504
December 5, 2023
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us